Filter Results

Clinical Studies

Closed for Enrollment

  • Mood Stabilizer Pharmacogenomics Biobank (MoStGEN) Rochester, Minn., Mankato, Minn., Austin, Minn., Scottsdale/Phoenix, Ariz.

    The purpose of this study is to create a larger database and bio-repository to examine pharmacogenomics in patients with BD type I and type II treated with mood stabilizing anticonvulsants, atypical antipsychotics and antidepressant medications. 
.